We can't find the internet
Attempting to reconnect
15705.1;7 PFLS-LS
Novel therapy against red blood cell diseases through blocking of calcium uptake
Zusammenfassung
Novel therapy against red blood cell diseases through blocking of calcium uptake
Weitere Texte
Abstract
We plan to use memantine for targeting NMDA receptors in red blood cells of patients with sickle cell disease in vivo. We envison reduction of hemolysis and in the vasooclusive crises. The answer we seek is whether memantine is well-tolerated by sickle cell disease patients. We aim to set ground for a bigger trial and market the compound for new hematological applications and to use NMDA receptors in red blood cells as a pharmacological target.
Beteiligte
Max Gassmann
Kontaktperson
Universität Zürich Max Gassmann Winterthurerstrasse 260 8057 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2013-06-30
- Enddatum
- 2014-06-28
- Bewilligte Gesamtkosten
- CHF 25000.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%